Once-Daily Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Once-Daily Upadacitinib Versus Placebo in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis (Measure Up 1 and Measure Up 2): Results From Two Replicate Double-Blind, Randomised Controlled Phase 3 Trials
Lancet 2021 Jun 05;397(10290)2151-2168, E Guttman-Yassky, HD Teixeira, EL Simpson, KA Papp, AL Pangan, A Blauvelt, D Thaçi, CY Chu, HC Hong, N Katoh, AS Paller, B Calimlim, Y Gu, X Hu, M Liu, Y Yang, J Liu, AR Tenorio, AD Chu, AD IrvineFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.